GlassScriptPhysician profile
Mirian Boci
NPI 1922272517
$6,874.17
in general payments reported to CMS, 2019-2025
47 companies · $2,399 in 2025
The $2,399 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $358 · 2021: $341 · 2022: $1,010 · 2023: $1,210 · 2024: $487 · 2025: $2,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,068 · Travel and Lodging: $909 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,068.37 |
| Travel and Lodging | $908.55 |
| Education | $118.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,827.00 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $619.71 | 2019-2025 | Botox, Lupron Depot |
| Antares Pharma, INC. | $450.01 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Procept Biorobotics Corporation | $407.45 | 2023-2025 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $329.24 | 2019-2022 | |
| Astellas Pharma US INC | $267.06 | 2019-2023 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $226.26 | 2019-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $202.05 | 2019-2025 | |
| Olympus America INC. | $193.14 | 2019-2025 | Itind System, Bovie |
| Urovant Sciences INC | $176.93 | 2021-2022 | |
| Pfizer INC. | $167.13 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $158.84 | 2019-2023 | Xiaflex |
| Coloplast Corp | $152.62 | 2019 | |
| Urogen Pharma, INC. | $143.81 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $137.84 | 2023-2025 | Gemtesa, Orgovyx |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $111.79 | 2022-2025 | Pylarify |
| C. R. Bard, INC. & Subsidiaries | $105.61 | 2023 | Bard Urinary Drainage Bag |
| Axonics, INC. | $103.07 | 2022-2024 | Bulkamid |
| Tolmar, INC. | $101.65 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $93.63 | 2019-2023 | Lithovue, Spaceoar Vue System - 10ml |
| Allergan, INC. | $82.98 | 2019-2020 | |
| Photocure INC | $70.45 | 2019 | |
| Cycle Pharmaceuticals INC | $64.32 | 2025 | Venxxiva |
| Endo USA, INC. | $61.97 | 2024 | Xiaflex |
| Tela Bio, INC. | $55.55 | 2022 | |
| Ferring Pharmaceuticals INC. | $54.07 | 2019-2024 | Adstiladrin |
| Agiliti Surgical, INC. | $52.27 | 2021 | |
| Blue Earth Diagnostics | $42.55 | 2019-2022 | |
| Caris Mpi, INC. | $40.17 | 2025 | Mi Cancer Seek |
| Innovation Technologies INC | $39.41 | 2022 | |
| Halozyme INC | $39.38 | 2023 | |
| Myriad Genetic Laboratories, INC. | $33.02 | 2021 | |
| Amgen INC. | $30.53 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $25.61 | 2024 | Bridion |
| Genzyme Corporation | $24.98 | 2022 | |
| Medtronic, INC. | $24.04 | 2022 | |
| Cook Medical LLC | $23.69 | 2024 | Resonance |
| Foundation Medicine, INC. | $19.91 | 2022 | |
| Galvanize Therapeutics, INC | $16.03 | 2025 | Aliya System |
| Ethicon US, LLC | $15.08 | 2019 | |
| Calyxo, INC. | $15.06 | 2024 | Cvac Aspiration System |
| Neotract INC. | $14.82 | 2020 | |
| Myovant Sciences INC. | $14.22 | 2022 | |
| Caldera Medical, INC | $13.29 | 2023 | Desara |
| Karl Storz Endoscopy-America | $12.79 | 2022 | |
| Convatec INC. | $12.04 | 2021 | |
| Travere Therapeutics, INC. | $1.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirian Boci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.